UK’s health department expected to spend £1B in pharma trade deal with USnews2026-02-04T00:01:38+00:00February 4th, 2026|Endpoints News|
Novo expects sales to fall in 2026, triggering selloffnews2026-02-03T20:07:25+00:00February 3rd, 2026|Endpoints News|
‘Turning around the Titanic’: How the incoming PBM reforms will transform CMSnews2026-02-03T19:34:01+00:00February 3rd, 2026|Endpoints News|
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earningsnews2026-02-03T12:51:41+00:00February 3rd, 2026|Endpoints News|
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelonews2026-02-03T12:03:52+00:00February 3rd, 2026|Endpoints News|
First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?news2026-02-02T20:42:11+00:00February 2nd, 2026|Endpoints News|
New CagriSema data show improvement over semaglutidenews2026-02-02T19:16:29+00:00February 2nd, 2026|Endpoints News|
SanegeneBio licenses RNAi candidate to Genentech for $200M upfrontnews2026-02-02T14:35:38+00:00February 2nd, 2026|Endpoints News|
Pharming’s immunodeficiency drug gets CRL for use in younger patientsnews2026-02-02T11:52:52+00:00February 2nd, 2026|Endpoints News|
European law changes mean drugmakers may have to grapple with generic competition soonernews2026-02-02T06:00:46+00:00February 2nd, 2026|Endpoints News|
